Abstract:
A composition which, upon reacting with thrombin, functions as a fibrin sealant and is characterized as being free of detectable levels of lipid enveloped virus activity, free of prothrombin complex and active thrombin, and contains no protease inhibitors or other non-human proteins. Also, described is a method for producing the composition.
Abstract:
A balloon dilation catheter includes a distal monorail section, to which a balloon is secured, and a catheter body tube including a monorail section. A guide tube extends through the balloon and has a proximal end sealed to a guide wire port in the body tube. A guide wire extends along the body tube and through the guide tube. To stiffen the body tube while maintaining maximized fluid flow area, a stainless steel hypotube extends through the proximal body tube, has a distal opening positioned adjacent the guide wire port and a solid reinforcing tapered distal end section that extends across the guide port. The hypotube can be fixed or removable. Alternatively, the hypotube divides the interior of the proximal body tube section into two separate flow passages to enable positive purging.
Abstract:
A peritoneal dialysis solution comprising as osmotic agents approximately 2.0 to about 6.0 % (w/v) maltodextrins and approximately 0.25 to about 2.0 % (w/v) amino acids. The peritoneal dialysis solution will also include other components such as sodium, chloride, lactate, bicarbonate, calcium, and magnesium.
Abstract:
A method and apparatus for implanting cells in a host is provided. In an embodiment, an implant assembly for a host tissue is provided comprising wall means defining a chamber for holding cells for implantation, the wall means including means for forming a porous boundary between the host tissue and the implanted cells in the chamber, the pore size of the boundary being sufficient to isolate the implanted cells from the immune response of the host tissue, and port means for providing selective access to the chamber.
Abstract:
A peristaltic pump tube holder includes a body (110) that supports a flexible tubing loop (134/136) in an erect, outwardly bowed position extending from the body for engagement with a peristaltic pump rotor (292). The holder also includes a receptacle (26) carrying the body. The receptacle (26) also includes a wall forming a chamber (152 A/B/C) that covers the flexible tubing loop and at least partially shields it from contact. The chamber further serves, during engagement between the tubing loop (134/136) and a peristaltic pump rotor (292), as a cover for the peristaltic pump rotor.
Abstract translation:蠕动泵管保持器包括主体(110),该主体(110)支撑柔性管道回路(134/136),其处于从主体延伸的直立的向外弯曲位置,用于与蠕动泵转子(292)接合。 支架还包括承载本体的容器(26)。 容器(26)还包括形成腔室(152A / B / C)的壁,其覆盖柔性管道环并且至少部分地将其遮蔽而不接触。 在该管路回路(134/136)和蠕动泵转子(292)之间的接合期间,该腔室还用作蠕动泵转子的盖子。
Abstract:
A peristaltic pump tube holder (22A/B/C) has a body (110) having first and second pump ports extending outside of it. The pump ports extend at an acute angle to receive a flexible tubing loop (134/136) and orient the tubing loop for engagement with an external pump rotor (292).
Abstract translation:蠕动泵管座(22A / B / C)具有主体(110),其具有在其外部延伸的第一和第二泵口。 泵口以锐角延伸,以接收柔性油管回路(134/136),并定向油管回路以与外部泵转子(292)接合。
Abstract:
A peristaltic pumping apparatus includes a peristaltic pump rotor (298) and pump race (296). A pump tube holder (250) includes a body for supporting a flexible tubing loop (134, 136) in an erect, outwardly bowed position for placement within the pump race and for removal from the pump race. A surface juxtaposed the peristaltic pump rotor and race carries a gripping jaw assembly (270). The gripping jaw assembly opens to receive the pump tube holder body as the body is moved toward the pump rotor to place the tubing loop within the pump race. The gripping jaw assembly closes to secure the pump tube holder body on the surface in an orientation in which the tubing loop lies within the pump race for engagement with the peristaltic pump rotor.
Abstract:
A drug delivery device (250) is provided for coupling a container (260) including a beneficial agent (262) to the device (250). The device (250) includes a substantially hollow member for housing a solution (256) wherein the hollow member includes an upper section (254) having flexible walls and a lower section (252) having substantially rigid walls. A spike (258) extends from the lower section (252) to provide fluid communication between an interior of the device (250) and the container (260). To this end, the beneficial agent (262) mixes with the solution (256) forming a mixture for administration to a patient. A cannula (266) and a plunger (264) are further provided for administration of the mixture (270) to the patient.
Abstract:
A compact pump assembly includes a plurality of axially aligned peristaltic pumps (112-118) for activating the flow of liquids through the conduits (44). A housing containing the pumps is provided with a removable cover (14) for retaining the pumps in the housing when the cover is closed, and for permitting removal of the pumps when the cover is opened. A reversible motor (132, 134) is mounted outside of the housing for driving each of the pumps. The pumps may be independently inactivated by individual release mechanisms provided on the common closure cover.
Abstract:
A low-profile single-lumen perfusion and fluid delivery balloon catheter for dilatation angioplasty procedures includes a small diameter single-lumen catheter shaft carrying a dilatation balloon adjacent to the distal end thereof. A perfusion conduit is also carried by the catheter shaft and traverses the dilatation balloon to provide perfusion blood flow past the balloon when the latter is inflated. The catheter may be used in mono-rail configuration to facilitate retracing of a subsequent catheter or other therapeutic device along the mono-rail guide wire back to the vascular site under treatment.